ATHA: Wutah pendapatan triwulanan Athira Pharma, Inc.

Athira Pharma, Inc. (ATHA) - logo korporat

Athira Pharma, Inc. (ATHA) is currently pivoting its strategy to focus on rare brain pathologies following setbacks with its lead drug candidate. Current quarterly revenue growth reflects the market reaction, where the latest parameter stands at 0.00. Development is being conducted in Washington with the involvement of external synthesis partners. The company plans to generate revenue from insurance reimbursements for innovative therapies targeting dementia and Alzheimer's disease.

ATHA Tambahing pendapatan triwulanan Athira (04.07.2022 - 12.01.2026)

Ringkesan rincian data analitis Athira (ATHA)

- rega saham lan target rega konsensus:
- indikator dhuwit lan arus kas:
Analisis umum perusahaan:athira.com (ATHA)
Produk sing diprodhuksi Athira Pharma Inc

This indicator measures the dynamics of quarterly inflows relative to previous periods, allowing investors to assess the pace of business expansion or stagnation through changes in quarterly revenue. For Athira Pharma, Inc. (ATHA), this metric is critical, as restructuring following failures in Alzheimer's therapy and a liquidity deficit make any revenue growth the primary marker of the company's viability against the risks of early-phase research.

Pesaing Athira Pharma, Inc.

BIIB - Wutah pendapatan kuartal marang kuartal|NBIX (Neurocrine Biosciences) - Wutah dodolan kuartal marang kuartal|RGC: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Axsome (AXSM)|Wutah pendapatan kuartal marang kuartal ACADIA Pharmaceuticals Inc|Wutah dodolan triwulanan Xenon Pharmaceuticals Inc (XENE)|Wutah pendapatan triwulanan VKTX|Wutah pendapatan triwulanan supernus.com (SUPN)|Wutah pendapatan kuartal marang kuartal Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Dinamika pendapatan kuartal marang kuartal|Harmony Corp - Wutah pendapatan triwulanan|BHVN: Wutah pendapatan kuartal marang kuartal|AMLX: Wutah pendapatan triwulanan|TRVI: Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Praxis Medicines|Tingkat wutah pendapatan sajrone kuartal Anavex AVXL|Wutah pendapatan kuartal marang kuartal CeriBell Corp (CBLL)|Owah-owahan dodolan kuartal marang kuartal PRTA|Wutah pendapatan triwulanan ALEC (Alector)|Annexon (ANNX) - Tingkat wutah pendapatan sajrone kuartal|OMER - Wutah pendapatan kuartal marang kuartal|NGNE (Neurogene) - Wutah dodolan kuartal marang kuartal|ACIU: Wutah pendapatan triwulanan|VYGR - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Neumora Therapeutics, Inc.|Wutah dodolan kuartal marang kuartal SCLX (Scilex)|Wutah dodolan triwulanan TVGN (Tevogen Bio)|Wutah pendapatan triwulanan Alpha Cognition Inc (ACOG)|Wutah pendapatan triwulanan CGTX (cogrx.com)|Tingkat wutah dodolan sajrone kuartal Inhibikase Pharma (IKT)|SAVA: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Assertio ASRT|COYA (coyatherapeutics.com) - Wutah dodolan triwulanan|Wutah dodolan kuartal marang kuartal VTGN|OVID (Ovid Therapeutics) - Wutah pendapatan triwulanan|Acumen Pharmaceuticals, Inc (ABOS) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal CervoMed, Inc. (CRVO)|ATHE - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan CLNN (Clene Inc.)|Tingkat wutah dodolan sajrone kuartal PepGen Inc. (PEPG)|JUNS - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Relmada Corp|ANVS (Annovis Bio, Inc.) - Wutah dodolan triwulanan|Grace Tx (GRCE) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan AIFF|Wutah pendapatan triwulanan anewmeds.com|Wutah pendapatan kuartal marang kuartal NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Tambahing pendapatan triwulanan|MetaVia - Wutah dodolan triwulanan|NRXS: Wutah dodolan kuartal marang kuartal|Helius Medical Technologies, Inc. - Wutah pendapatan triwulanan|PASG: Wutah pendapatan kuartal marang kuartal|Neuphoria (NEUP) - Wutah pendapatan kuartal marang kuartal|Minerva Neurosciences - Tambahing pendapatan triwulanan|ADXN (Addex Therapeutics Ltd.) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ALZN (Alzamend Neuro)|Wutah pendapatan kuartal marang kuartal Cyclerion Therapeutics Inc. (CYCN)|Wutah pendapatan triwulanan Protagenic Therapeutics, Inc. (PTIX)|Wutah pendapatan triwulanan KTTA (Pasithea Therapeutics Corp)|CRGT - Wutah dodolan triwulanan|ATXI - Wutah pendapatan kuartal marang kuartal|BCLI: Wutah pendapatan kuartal marang kuartal|Cara Therapeutics (CARA) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Chromocell Therapeutics Corp (CHRO)|Wutah dodolan triwulanan ELYM|Tingkat wutah pendapatan sajrone kuartal intracellulartherapies.com ITCI|Wutah pendapatan kuartal marang kuartal Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal NKGen NKGN|Wutah pendapatan triwulanan NeuroBo Pharmaceuticals Inc NRBO|SAGE: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Synaptogenix, Inc SNPX|TRVN: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Vigil Neuroscience (VIGL)|Wutah pendapatan kuartal marang kuartal Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal